Design Therapeutics (DSGN) Other Non Operating Income (2020 - 2024)

Design Therapeutics (DSGN) has 5 years of Other Non Operating Income data on file, last reported at $3.2 million in Q3 2024.

• For the quarter ending Q3 2024, Other Non Operating Income rose 5.74% year-over-year to $3.2 million; the trailing twelve-month figure through Sep 2024 stood at $13.0 million (up 29.01% YoY), and the FY2023 full-year result was $11.3 million, up 164.36% from the prior year.
• Other Non Operating Income fell to $3.2 million in Q3 2024, from $3.2 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $3.3 million in Q1 2024 to a low of -$40000.0 in Q1 2020.
• A 5-year average of $1.4 million and a median of $640000.0 in 2022 frame the typical range for Other Non Operating Income.
• Across the five-year window, Other Non Operating Income slumped 69.84% in 2021 and soared 7731.58% in 2022, its largest moves.
• Tracing DSGN's Other Non Operating Income over 5 years: stood at $6000.0 in 2020, then jumped by 933.33% to $62000.0 in 2021, then surged by 3209.68% to $2.1 million in 2022, then jumped by 59.8% to $3.3 million in 2023, then retreated by 2.2% to $3.2 million in 2024.
• Business Quant data shows DSGN's Other Non Operating Income at $3.2 million in Q3 2024, $3.2 million in Q2 2024, and $3.3 million in Q1 2024.